Objectives: This study sought to evaluate predictors of stroke during left ventricular assist
device (LVAD) support from data available prior to implantation, and quantify stroke-related …

Over the last decade, advances in left ventricular assist device (LVAD) therapy have
revolutionized care of advanced heart failure (HF) patients, with much improved long-term …

Aims Left ventricular assist devices (LVADs) have reduced the mortality of patients with
advanced heart failure both as bridge‐to‐transplant and as destination therapy. However …

Background Incident liver dysfunction after left ventricular assist device implantation has
been previously associated with adverse outcomes, yet data on perioperative risk markers …

Objectives Sarcopenia in patients with heart failure (HF) is associated with poor prognosis.
Cardiac rehabilitation (CR) decreases the incidence of adverse events in patients with HF …

Aims The measurement of muscle mass reflects the physical components of frailty, which
might affect postoperative outcomes in patients undergoing left ventricular assist device …

Background Sarcopenia and hypoalbuminemia have been identified as independent
predictors of increased adverse outcomes, including mortality and readmissions, in …

The optimal timing of left ventricular assist device (LVAD) implantation in the management of
advanced heart failure remains controversial. We hypothesize that in patients with …

Background: Right ventricular stroke work index is a useful but invasively measured
parameter that can be used to predict right heart failure following continuous-flow left …

Aim Sarcopenia is a geriatric condition characterized by progressive loss of skeletal muscle
mass and function. The definition and diagnosis of sarcopenia is inconsistent between …